{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:02:04Z","timestamp":1787929324781,"version":"build-2784847793"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s10238-019-00546-x","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T18:09:40Z","timestamp":1548353380000},"page":"255-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Serum miR-122 levels correlate with diabetic retinopathy"],"prefix":"10.1007","volume":"19","author":[{"given":"Nina","family":"Pastukh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Meerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorina","family":"Kalish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanin","family":"Jabaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7467-4222","authenticated-orcid":false,"given":"Arnon","family":"Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"546_CR1","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1038\/nature08933","volume":"464","author":"JA Bluestone","year":"2010","unstructured":"Bluestone JA, Herold K, Eisenbarth G. Genetics, pathogenesis and clinical interventions in type 1 diabetes. Nature. 2010;464:1293\u2013300.","journal-title":"Nature"},{"key":"546_CR2","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","volume":"383","author":"SE Kahn","year":"2014","unstructured":"Kahn SE, Cooper ME, Del Prato S. Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future. Lancet. 2014;383:1068\u201383.","journal-title":"Lancet"},{"key":"546_CR3","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311\u201321.","journal-title":"Diabetes Res Clin Pract"},{"key":"546_CR4","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1478-7954-8-29","volume":"8","author":"JP Boyle","year":"2010","unstructured":"Boyle JP, Thompson TJ, Gregg EW, Barker LE, Williamson DF. Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010;8:29.","journal-title":"Popul Health Metr"},{"key":"546_CR5","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1001\/archopht.1984.01040030398010","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520\u20136.","journal-title":"Arch Ophthalmol"},{"key":"546_CR6","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1001\/archopht.1984.01040030405011","volume":"102","author":"R Klein","year":"1984","unstructured":"Klein R, Klein BEK, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol. 1984;102:527\u201332.","journal-title":"Arch Ophthalmol"},{"key":"546_CR7","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1056\/NEJMra021678","volume":"350","author":"NR Frank","year":"2004","unstructured":"Frank NR. Diabetic retinopathy. N Engl J Med. 2004;350:48\u201358.","journal-title":"N Engl J Med"},{"key":"546_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1001\/archopht.117.11.1487","volume":"117","author":"R Klein","year":"1999","unstructured":"Klein R, Klein BEK, Moss SE, Cruickshanks KJ. Association of ocular disease and mortality in a diabetic population. Arch Ophthalmol. 1999;117:1487\u201395.","journal-title":"Arch Ophthalmol"},{"key":"546_CR9","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.2337\/diacare.15.12.1875","volume":"15","author":"R Klein","year":"1992","unstructured":"Klein R, Klein BEK, Moss SE. The epidemiology of proliferative diabetic retinopathy. Diabetes Care. 1992;15:1875\u201391.","journal-title":"Diabetes Care"},{"key":"546_CR10","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","volume":"373","author":"M Tancredi","year":"2015","unstructured":"Tancredi M, Rosengren A, Svensson A-M, et al. Excess mortality among persons with type 2 diabetes. N Engl J Med. 2015;373:1720\u201332.","journal-title":"N Engl J Med"},{"key":"546_CR11","doi-asserted-by":"publisher","unstructured":"Blum A, Pastukh N, Socea D, Jabaly H. Levels of adhesion molecules in peripheral blood correlate with stages of diabetic retinopathy and may serve as bio markers for microvascular complications. Cytokine. 2017. https:\/\/doi.org\/10.1016\/j.cyto.2017.10.014 [Epub ahead of print].","DOI":"10.1016\/j.cyto.2017.10.014"},{"issue":"4","key":"546_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1684\/ecn.2012.0321","volume":"23","author":"A Blum","year":"2012","unstructured":"Blum A, Socea D, Ben-Shushan RS, Keinan-Boker L, Naftali M, Segol G, Tamir S. A decrease in VEGF and inflammatory markers is associated with diabetic proliferative retinopathy. Eur Cytokine Netw. 2012;23(4):158\u201362.","journal-title":"Eur Cytokine Netw"},{"issue":"2","key":"546_CR13","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"7","key":"546_CR14","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.2337\/db11-0171","volume":"60","author":"SL Fernandez-Valverde","year":"2011","unstructured":"Fernandez-Valverde SL, Taft RJ, Mattick JS. MicroRNAs in \u03b2-cell biology, insulin resistance, diabetes and its complications. Diabetes. 2011;60(7):1825\u201331.","journal-title":"Diabetes"},{"issue":"9","key":"546_CR15","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/nrendo.2013.86","volume":"9","author":"C Guay","year":"2013","unstructured":"Guay C, Regazzi R. Circulating microRNAs as novel biomarkers for diabetes mellitus. Nat Rev Endocrinol. 2013;9(9):513\u201321.","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"546_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/cvr\/cvr300","volume":"93","author":"S Shantikumar","year":"2011","unstructured":"Shantikumar S, Caporali A, Emanueli C. Role of microRNAs in diabetes and its cardiovascular complications. Cardiovasc Res. 2011;93(4):583\u201393.","journal-title":"Cardiovasc Res"},{"issue":"4\u20136","key":"546_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1159\/000218169","volume":"23","author":"AK Pandey","year":"2009","unstructured":"Pandey AK, Agarwal P, Kaur K, Datta M. MicroRNAs in diabetes: tiny players in big disease. Cellular Physiol Biochem. 2009;23(4\u20136):221\u201332.","journal-title":"Cellular Physiol Biochem"},{"issue":"12","key":"546_CR18","doi-asserted-by":"publisher","first-page":"e0188980","DOI":"10.1371\/journal.pone.0188980","volume":"12","author":"P Candia de","year":"2017","unstructured":"de Candia P, Spinetti G, Specchia C, et al. A unique plasma microRNA profile defines type 2 diabetes progression. PLoS ONE. 2017;12(12):e0188980. https:\/\/doi.org\/10.1371\/journal.pone.0188980 .","journal-title":"PLoS ONE"},{"issue":"15","key":"546_CR19","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franzen S, et al. Mortality and cardiovasculuar disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407\u201318.","journal-title":"N Engl J Med"},{"issue":"5","key":"546_CR20","first-page":"57","volume":"5","author":"A Blum","year":"2016","unstructured":"Blum A, Pastukh N, Socea D, Hanin J. Colony forming unites-endothelial progenitor cells (CFU-EPCs): a surrogate marker for diabetic retinopathy and high cardiovascular mortality rate. Int J Pharma Res Rev. 2016;5(5):57\u201362.","journal-title":"Int J Pharma Res Rev"},{"key":"546_CR21","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","volume":"129","author":"C Stegemann","year":"2014","unstructured":"Stegemann C, Pechlaner T, Willeit P, et al. Lipidpmics profiling and risk of cardiovascular disease in the prospective population-based bruneck study. Circulation. 2014;129:1821\u201331.","journal-title":"Circulation"},{"key":"546_CR22","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.jacc.2014.03.061","volume":"64","author":"P Willeit","year":"2014","unstructured":"Willeit P, Kiechl S, Kronenberg F, et al. Discrimination and net reclassification of cardiovascular risk with lipoprotein (a): prospective 15-year outcomes in the Bruneck Study. J Am Coll Cardiol. 2014;64:851\u201360.","journal-title":"J Am Coll Cardiol"},{"key":"546_CR23","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.jacc.2012.03.056","volume":"60","author":"A Zampetaki","year":"2012","unstructured":"Zampetaki A, Willeit P, Tilling L, et al. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60:290\u20139.","journal-title":"J Am Coll Cardiol"},{"key":"546_CR24","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm.3084","volume":"19","author":"S Kiechl","year":"2013","unstructured":"Kiechl S, Wittmann J, Giacceari A, et al. Blockade of receptor activator of nuclear factor-k B (RNAKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med. 2013;19:358\u201363.","journal-title":"Nat Med"},{"key":"546_CR25","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1161\/ATVBAHA.110.205492","volume":"30","author":"P Willeit","year":"2010","unstructured":"Willeit P, Willeit J, Brandstatter A, et al. Cellular aging reflected by leukocyte telomere length predicts advanced atherosclerosis and cardiovascular disease risk. Arterioscler Thromb Vasc Biol. 2010;30:1649\u201356.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"546_CR26","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"PS Sever","year":"2003","unstructured":"Sever PS, Dahlof B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ACOT-LLA): a multicenter randomized controlled trial. Lancet. 2003;361:1149\u201358.","journal-title":"Lancet"},{"key":"546_CR27","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/S0140-6736(05)67186-3","volume":"366","author":"NR Poulter","year":"2005","unstructured":"Poulter NR, Wedel H, Dahlof B, et al. Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). Lancet. 2005;366:907\u201313.","journal-title":"Lancet"},{"issue":"Suppl 1","key":"546_CR28","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1038\/sj.jhh.1001089","volume":"15","author":"A Stanton","year":"2001","unstructured":"Stanton A, Fitzgerald D, Hughes A, et al. An intensive phenotyping study to enable the future examination of genetic influences on hypertension-associated cardiovascular disease. J Hum Hypertens. 2001;15(Suppl 1):S13\u20138.","journal-title":"J Hum Hypertens"},{"issue":"2","key":"546_CR29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.2337\/db16-0731","volume":"66","author":"P Willwit","year":"2017","unstructured":"Willwit P, Skroblin P, Moschen AR, et al. Circulating microRNA-122 is associated with the risk of new onset metabolic syndrome and type 2 diabetes. Diabetes. 2017;66(2):347\u201357.","journal-title":"Diabetes"},{"key":"546_CR30","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1253\/circj.CJ-16-0568","volume":"80","author":"N Cortez-Dias","year":"2016","unstructured":"Cortez-Dias N, Costa MC, Carrilho-Ferreira P, et al. Circulating miR-122-5p\/miR-133b ratio is a specific early prognostic biomarker in acute myocardial infarction. Circ J. 2016;80:2183\u201391.","journal-title":"Circ J"},{"key":"546_CR31","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/1476-511X-11-55","volume":"11","author":"W Gao","year":"2012","unstructured":"Gao W, He HW, Wang ZM, et al. Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease. Lipids Health Dis. 2012;11:55\u201363.","journal-title":"Lipids Health Dis"},{"issue":"10","key":"546_CR32","first-page":"620","volume":"19","author":"A Blum","year":"2017","unstructured":"Blum A, Yehuda H, Geron N, Meerson A. Elevated levels of miR-122 in serum may contribute to improved endothelial function and lower oncologic risk following bariatric surgery. IMAJ. 2017;19(10):620\u20134.","journal-title":"IMAJ"},{"key":"546_CR33","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/msb.2010.58","volume":"6","author":"J Burchard","year":"2010","unstructured":"Burchard J, Zhang C, Liu AM, et al. microRNA-122 as a regulator of mitochindrial metabolic gene network in hepatocellular carcinoma. Mol Syst Biol. 2010;6:402. https:\/\/doi.org\/10.1038\/msb.2010.58 .","journal-title":"Mol Syst Biol"},{"key":"546_CR34","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.12659\/MSM.902936","volume":"23","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Li H, Chen S, et al. Knockdown of MicroRNA-122 protects H9c2 cardiomyocytes from hypoxia induced apoptosis and promotes autophagy. Med Sci Monit. 2017;23:4284\u201390.","journal-title":"Med Sci Monit"},{"issue":"9","key":"546_CR35","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1111\/jcmm.13144","volume":"21","author":"W Dhahri","year":"2017","unstructured":"Dhahri W, Dussault S, Haddad P, et al. Reduced expression of let-7f activates TGF-\u03b2\/ALK5 pathway and leads to impaired ischaemia-induced neovascularization after cigarette smoke exposure. J Cell Mol Med. 2017;21(9):2211\u201322.","journal-title":"J Cell Mol Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10238-019-00546-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-019-00546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T14:50:38Z","timestamp":1606143038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10238-019-00546-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["546"],"URL":"https:\/\/doi.org\/10.1007\/s10238-019-00546-x","relation":{},"ISSN":["1591-8890","1591-9528"],"issn-type":[{"value":"1591-8890","type":"print"},{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"12 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}